The DEA banned a drug some opioid users called a miracle

Researchers say the Schedule I ban could kill studies of a promising opioid treatment.
Read the original at Ars Technica ↗
Researchers say the Schedule I ban could kill studies of a promising opioid treatment.
Read the original at Ars Technica ↗